A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance

European Urology

Volumn 56, Issue 6, 2009, Pages 981-988

  van As, Nicholas J ^a   de Souza, Nandita M ^a   Riches, Sophie F ^a   Morgan, Veronica A ^a   Sohaib, Sayid A ^a   Dearnaley, David P ^a   Parker, Chris C ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Active surveillance; Imaging; Prognostic factors; Prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER SCREENING; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FOLLOW UP; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE CARCINOMA; REPEAT PROCEDURE; TREATMENT REFUSAL;

AGED; BIOPSY; DIFFUSION MAGNETIC RESONANCE IMAGING; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; ROC CURVE;

EID: 70350574817     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.11.051     Document Type: Article

References (27)

1. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
2. Albertsen P.C., Hanley J.A., Gleason D.F., and Barry M.J. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280 (1998) 975-980
3. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969-974
4. Zelefsky M.J., Lyass O., Fuks Z., et al. Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. J Clin Oncol 16 (1998) 3380-3385
5. Chism D.B., Hanlon A.L., Horwitz E.M., Feigenberg S.J., and Pollack A. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 380-385
6. Cabrera A.R., Coakley F.V., Westphalen A.C., et al. Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology 247 (2008) 444-450
7. Castillo M., Smith J.K., Kwock L., and Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22 (2001) 60-64
8. Anderson A.W., Xie J., Pizzonia J., et al. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging 18 (2000) 689-695
9. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep 50 (1966) 125-128
10. Gleason D.F., and Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111 (1974) 58-64
11. Van As N., Charles-Edwards E., Jackson A., et al. Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. Br J Radiol 81 (2008) 456-462
12. Desouza N.M., Riches S.F., Vanas N.J., et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. Clin Radiol 63 (2008) 774-782
13. Venkitaraman R., Norman A., Woode-Amissah R., et al. Predictors of histological disease progression in untreated, localized prostate cancer. J Urol 178 (2007) 833-837
14. Kattan M.W. A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy. Nat Clin Pract Urol 5 (2008) 138-139
15. Zelefsky M.J., Kattan M.W., Fearn P., et al. Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer. Urology 70 (2007) 283-287
16. Van As N.J., Norman A.R., Thomas K., et al. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol 54 (2008) 1297-1305
17. Van As N.J., and Parker C.C. Active surveillance with selective radical treatment for localized prostate cancer. Cancer 13 (2007) 289-294
18. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262
19. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
20. Haider M.A., van der Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189 (2007) 323-328
21. Morgan V.A., Kyriazi S., Ashley S.E., and DeSouza N.M. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol 48 (2007) 695-703
22. D'Amico A.V., Chen M.H., Roehl K.A., and Catalona W.J. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351 (2004) 125-135
23. Carter H.B., Ferrucci L., Kettermann A., et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521-1527
24. D'Amico A.V., Renshaw A.A., Sussman B., and Chen M.H. Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy. JAMA 294 (2005) 440-447
25. Cuzick J., Fisher G., Kattan M.W., et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 95 (2006) 1186-1194
26. Van As N, Norman A, Woode-Amissah R, et al. Active surveillance of low risk localized prostate cancer: baseline predictors of disease progression. In: Proceedings of the American Society of Clinical Oncology Prostate Cancer Symposium; February 22-24, 2007; Orlando, Florida, USA. Abstract 319.
27. Venkitaraman R., Norman A., Woode-Amissah R., et al. Prostate-specific antigen velocity in untreated, localized prostate cancer. BJU Int 101 (2007) 161-164